aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.740
-0.030 (-0.80%)
At close: Dec 27, 2024, 4:00 PM
3.789
+0.049 (1.31%)
After-hours: Dec 27, 2024, 7:07 PM EST
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $313.94 million as of December 27, 2024. Its market cap has increased by 350.42% in one year.
Market Cap
313.94M
Enterprise Value
261.53M
1-Year Change
350.42%
Ranking
Category
Stock Price
3.74
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $313.94M, a decrease of -6.87%. That is a compound annual growth rate of -0.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 26, 2024 | 316.50M | 283.17% |
Dec 29, 2023 | 82.60M | 30.08% |
Dec 30, 2022 | 63.50M | -69.41% |
Dec 31, 2021 | 207.60M | 428.24% |
Dec 31, 2020 | 39.30M | 142.59% |
Dec 31, 2019 | 16.20M | 8.72% |
Dec 31, 2018 | 14.90M | -85.70% |
Dec 29, 2017 | 104.20M | 104.31% |
Dec 30, 2016 | 51.00M | -78.06% |
Dec 31, 2015 | 232.50M | -31.03% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Trevi Therapeutics | 323.60M |
Revance Therapeutics | 323.10M |
Voyager Therapeutics | 322.84M |
XOMA Royalty | 321.43M |
Viemed Healthcare | 318.11M |
Nyxoah | 314.65M |
enGene Holdings | 313.00M |
Aclaris Therapeutics | 311.87M |